Antithyroid drug-induced fetal goitrous hypothyroidism

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Antithyroid drug-induced fetal goitrous hypothyroidism. / Bliddal, Sofie; Rasmussen, Ase Krogh; Sundberg, Karin; Brocks, Vibeke; Feldt-Rasmussen, Ulla; Medscape; Bliddal, Sofie; Rasmussen, Åse Krogh.

I: Nature Reviews Endocrinology, Bind 7, Nr. 7, 01.01.2011, s. 396-406.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Bliddal, S, Rasmussen, AK, Sundberg, K, Brocks, V, Feldt-Rasmussen, U, Medscape, Bliddal, S & Rasmussen, ÅK 2011, 'Antithyroid drug-induced fetal goitrous hypothyroidism', Nature Reviews Endocrinology, bind 7, nr. 7, s. 396-406. https://doi.org/10.1038/nrendo.2011.34, https://doi.org/10.1038/nrendo.2011.34

APA

Bliddal, S., Rasmussen, A. K., Sundberg, K., Brocks, V., Feldt-Rasmussen, U., Medscape, Bliddal, S., & Rasmussen, Å. K. (2011). Antithyroid drug-induced fetal goitrous hypothyroidism. Nature Reviews Endocrinology, 7(7), 396-406. https://doi.org/10.1038/nrendo.2011.34, https://doi.org/10.1038/nrendo.2011.34

Vancouver

Bliddal S, Rasmussen AK, Sundberg K, Brocks V, Feldt-Rasmussen U, Medscape o.a. Antithyroid drug-induced fetal goitrous hypothyroidism. Nature Reviews Endocrinology. 2011 jan. 1;7(7):396-406. https://doi.org/10.1038/nrendo.2011.34, https://doi.org/10.1038/nrendo.2011.34

Author

Bliddal, Sofie ; Rasmussen, Ase Krogh ; Sundberg, Karin ; Brocks, Vibeke ; Feldt-Rasmussen, Ulla ; Medscape ; Bliddal, Sofie ; Rasmussen, Åse Krogh. / Antithyroid drug-induced fetal goitrous hypothyroidism. I: Nature Reviews Endocrinology. 2011 ; Bind 7, Nr. 7. s. 396-406.

Bibtex

@article{50e7d3d8ce7b4707bb9199b09e16e9e4,
title = "Antithyroid drug-induced fetal goitrous hypothyroidism",
abstract = "Maternal overtreatment with antithyroid drugs can induce fetal goitrous hypothyroidism. This condition can have a critical effect on pregnancy outcome, as well as on fetal growth and neurological development. The purpose of this Review is to clarify if and how fetal goitrous hypothyroidism can be prevented, and how to react when prevention has failed. Understanding the importance of pregnancy-related changes in maternal thyroid status when treating a pregnant woman is crucial to preventing fetal goitrous hypothyroidism. Maternal levels of free T(4) are the most consistent indication of maternal and fetal thyroid status. In patients with fetal goitrous hypothyroidism, intra-amniotic levothyroxine injections improve fetal outcome. The best way to avoid maternal overtreatment with antithyroid drugs is to monitor closely the maternal thyroid status, especially estimates of free T(4) levels.",
author = "Sofie Bliddal and Rasmussen, {Ase Krogh} and Karin Sundberg and Vibeke Brocks and Ulla Feldt-Rasmussen and Ulla Feldt-Rasmussen and Sofie Bliddal and Rasmussen, {{\AA}se Krogh}",
year = "2011",
month = jan,
day = "1",
doi = "10.1038/nrendo.2011.34",
language = "English",
volume = "7",
pages = "396--406",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "nature publishing group",
number = "7",

}

RIS

TY - JOUR

T1 - Antithyroid drug-induced fetal goitrous hypothyroidism

AU - Bliddal, Sofie

AU - Rasmussen, Ase Krogh

AU - Sundberg, Karin

AU - Brocks, Vibeke

AU - Feldt-Rasmussen, Ulla

AU - Medscape

AU - Bliddal, Sofie

AU - Rasmussen, Åse Krogh

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Maternal overtreatment with antithyroid drugs can induce fetal goitrous hypothyroidism. This condition can have a critical effect on pregnancy outcome, as well as on fetal growth and neurological development. The purpose of this Review is to clarify if and how fetal goitrous hypothyroidism can be prevented, and how to react when prevention has failed. Understanding the importance of pregnancy-related changes in maternal thyroid status when treating a pregnant woman is crucial to preventing fetal goitrous hypothyroidism. Maternal levels of free T(4) are the most consistent indication of maternal and fetal thyroid status. In patients with fetal goitrous hypothyroidism, intra-amniotic levothyroxine injections improve fetal outcome. The best way to avoid maternal overtreatment with antithyroid drugs is to monitor closely the maternal thyroid status, especially estimates of free T(4) levels.

AB - Maternal overtreatment with antithyroid drugs can induce fetal goitrous hypothyroidism. This condition can have a critical effect on pregnancy outcome, as well as on fetal growth and neurological development. The purpose of this Review is to clarify if and how fetal goitrous hypothyroidism can be prevented, and how to react when prevention has failed. Understanding the importance of pregnancy-related changes in maternal thyroid status when treating a pregnant woman is crucial to preventing fetal goitrous hypothyroidism. Maternal levels of free T(4) are the most consistent indication of maternal and fetal thyroid status. In patients with fetal goitrous hypothyroidism, intra-amniotic levothyroxine injections improve fetal outcome. The best way to avoid maternal overtreatment with antithyroid drugs is to monitor closely the maternal thyroid status, especially estimates of free T(4) levels.

U2 - 10.1038/nrendo.2011.34

DO - 10.1038/nrendo.2011.34

M3 - Journal article

C2 - 21403664

VL - 7

SP - 396

EP - 406

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

SN - 1759-5029

IS - 7

ER -

ID: 34104368